Rite Aid Corp (RAD)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Rite Aid Corp (RAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012233
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rite Aid Corp (Rite Aid) is retail drugstore chain. The company sells prescription drugs and a wide range of other merchandise such as, over-the-counter (OTC) medications, personal care items, health and beauty aids, cosmetics, household items, beverages, convenience foods, greeting cards, seasonal merchanise, photo processing and others. Rite Aid services portfolio include pharmacy-related solutions including fully integrated mail, specialty and compounding pharmacy services. The company also has a technology which helps its customer to fill or refill their prescription through internet under website www.riteaid.com. It operates through subsidiaries and retail drugstores in the US. Rite Aid is headquartered in Camp Hill, Pennsylvania, the US.

Rite Aid Corp (RAD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Rite Aid Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Rite Aid Corp, Medical Devices Deals, 2011 to YTD 2017 10
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Rite Aid Corp, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
TPG Capital Completes Acquisition Of Envision Pharma 12
Partnerships 14
RediClinic Enters into Joint Venture Agreement with MultiCare Health System 14
Debt Offering 15
Rite Aid Raises USD1.8 Billion in Private Placement of 6.125% Notes Due 2023 15
Rite Aid Completes Private Placement Of Notes Due 2021 For US$810 Million 16
Acquisition 17
Envision Pharma Acquires MedTrak 17
Rite Aid Acquires RediClinic, Operator Of Healthcare Clinics 18
Rite Aid Acquires Health Dialog Services From British United Provident Association 19
Envision Pharma Acquires ProScribe 20
Envision Pharma Acquires Laker Software 21
Rite Aid Acquires Kings Pharmacy East 22
Jean Coutu Completes Sale Of Minority Stake In Rite Aid For US$160 Million 23
MedTrak Services Acquires Beyond Rx From Pharmacy First 24
Rite Aid Corp – Key Competitors 25
Rite Aid Corp – Key Employees 26
Rite Aid Corp – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Financial Announcements 30
Sep 28, 2017: Rite Aid Reports Fiscal 2018 Second Quarter Results 30
Sep 22, 2016: Rite Aid Reports Fiscal 2017 Second Quarter Results 31
Jun 06, 2016: Rite Aid Reports Fiscal 2017 First Quarter Results 32
Apr 07, 2016: Rite Aid Reports Fiscal 2016 Fourth Quarter and Full Year Results 33
Corporate Communications 36
Nov 17, 2017: Rite Aid Announces Senior Management Changes in Category Management 36
Nov 14, 2017: Rob Mullins Named Senior Vice President of Store Operations, Western Division 37
Nov 02, 2017: Rite Aid: Matt Schroeder Named Senior Vice President, Chief Accounting Officer and Treasurer 38
Sep 28, 2017: Kermit Crawford Joins Rite Aid as President and Chief Operating Officer of Rite Aid 39
Jan 23, 2017: Ken Black Named Senior Vice President of Human Resources and Chief Human Resources Officer 40
Feb 29, 2016: Rite Aid Announces Results of First-Ever Rite Aid Innovation Challenge 41
Feb 10, 2016: Rite Aid Foundation’s Big Hearts Give Challenge Awards Over $1.5 Million to KidCents Charities 42
Product News 43
Sep 27, 2016: Rite Aid Expands Naloxone Dispensing Program in Four Additional States 43
Aug 29, 2016: Rite Aid to Offer Naloxone Without Prescription in 13 States 44
Jul 20, 2017: Rite Aid Expands Naloxone Dispensing Program to Michigan and South Carolina 45
Jun 09, 2016: High Patient Satisfaction And Demand For IBgard Results In Expansion Of Availability To Rite Aid Stores Nationwide 46
Feb 15, 2017: Rite Aid Expands Naloxone Dispensing Program in Six Additional States 47
Other Significant Developments 48
Aug 17, 2016: Rite Aid and EnvisionRx Collaborate to Improve Medication Adherence and Health Outcomes Through New Rx90 Program 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Rite Aid Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Rite Aid Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Rite Aid Corp, Deals By Therapy Area, 2011 to YTD 2017 9
Rite Aid Corp, Medical Devices Deals, 2011 to YTD 2017 10
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
TPG Capital Completes Acquisition Of Envision Pharma 12
RediClinic Enters into Joint Venture Agreement with MultiCare Health System 14
Rite Aid Raises USD1.8 Billion in Private Placement of 6.125% Notes Due 2023 15
Rite Aid Completes Private Placement Of Notes Due 2021 For US$810 Million 16
Envision Pharma Acquires MedTrak 17
Rite Aid Acquires RediClinic, Operator Of Healthcare Clinics 18
Rite Aid Acquires Health Dialog Services From British United Provident Association 19
Envision Pharma Acquires ProScribe 20
Envision Pharma Acquires Laker Software 21
Rite Aid Acquires Kings Pharmacy East 22
Jean Coutu Completes Sale Of Minority Stake In Rite Aid For US$160 Million 23
MedTrak Services Acquires Beyond Rx From Pharmacy First 24
Rite Aid Corp, Key Competitors 25
Rite Aid Corp, Key Employees 26
Rite Aid Corp, Other Locations 28
Rite Aid Corp, Subsidiaries 28

★海外企業調査レポート[Rite Aid Corp (RAD)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sodra Skogsagarna ekonomisk forening:企業の戦略的SWOT分析
    Sodra Skogsagarna ekonomisk forening - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Alstom SA (ALO):電力:M&Aディール及び事業提携情報
    Summary Alstom SA (Alstom) is a marketer and developer of transport systems. The company offers a wide range of solutions ranging from high-speed trains to metros and tramways including customized services such as maintenance and modernization, and infrastructure up to signaling solutions. It design …
  • Admedes GmbH:企業の戦略的SWOT分析
    Admedes GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Realtek Semiconductor Corp. (2379):企業の財務・戦略的SWOT分析
    Realtek Semiconductor Corp. (2379) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Plymouth Tube Company:企業の戦略的SWOT分析
    Plymouth Tube Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • InVitae Corp (NVTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Invitae Corp (Invitae), formerly Locus Development Inc, is a genetic information company which processes DNA-containing samples, analyzes information about patient-specific genetic variation and generates test reports for clinicians and their patients. The company’s portfolio of diagnostic t …
  • QPS Holdings LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary QPS Holdings LLC (QPS) is a contract research organization that offers bioanalytical contract services. The organization’s services include neuropharmacology, toxicology, DMPK, bioanalysis, translational medicine, clinical development, clinical research, and dermal and transdermal research s …
  • Spotlight Innovation Inc (STLT):企業の財務・戦略的SWOT分析
    Summary Spotlight Innovation Inc (Spotlight Innovation), formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company’s product pipeline includes drug candidates for the treatment of cancer derived from specialized …
  • Obuv Rossii OOO (OBUV):企業の財務・戦略的SWOT分析
    Obuv Rossii OOO (OBUV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Grupo Aval Acciones Y Valores Sa:企業の戦略・SWOT・財務分析
    Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report Summary Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Flexion Therapeutics Inc (FLXN)-製薬・医療分野:企業M&A・提携分析
    Summary Flexion Therapeutics Inc (Flexion) is a pharmaceutical company that develops and commercializes pain therapies. The company's products comprise FX006, FX007, and FX005. Its FX005 is a p38 mitogen-activated protein, kinase inhibitor that contains both analgesic and anti-inflammatory propertie …
  • West Cornwall Pasty Co. Ltd:企業の戦略・SWOT・財務情報
    West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • DexCom Inc (DXCM):企業の製品パイプライン分析
    Summary Dexcom Inc (Dexcom) is a medical device company that designs, develops and commercializes continuous glucose monitoring (CGM) systems. The company’s major products include integrated CGM systems for adults and pediatric use, Dexcom G5 mobile CGM system, Dexcom G4 PLATINUM CGM system, associa …
  • Kin and Carta plc (KCT):企業の財務・戦略的SWOT分析
    Kin and Carta plc (KCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Japan Airlines Co Ltd:企業の戦略・SWOT・財務情報
    Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Marsh & McLennan Companies, Inc.:企業の戦略・SWOT・財務情報
    Marsh & McLennan Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Marsh & McLennan Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Blue Energy Ltd (BUL):石油・ガス:M&Aディール及び事業提携情報
    Summary Blue Energy Ltd (BEL) is an oil and gas company that provides exploration and development services. The company provides exploration and production of coal seam gas and conventional oil, and gas resources in Australia. Its projects portfolio includes carpentaria basin, bowen basin, galilee b …
  • Bone Therapeutics SA (BOTHE):企業の財務・戦略的SWOT分析
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • LafargeHolcim Ltd.:企業のM&A・事業提携・投資動向
    LafargeHolcim Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LafargeHolcim Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • NanoString Technologies Inc (NSTG):企業の財務・戦略的SWOT分析
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆